ScripIn the previous installment of Scrip Asks…What Does 2023 Hold For Biopharma? , we asked what technological advance would have the biggest impact on biopharma in 2023. Artificial intelligence was a fe
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Mersana Ends 2022 With Third Big Pharma
ScripFrom research into the single-chain antibody structures found in camelids (camels and other animals), Ordaos Bio is trying to harness the potential of mini-proteins, a new category that combines som